Table 3.
Post-discharge outcomes among hospice live discharges, by ADRD status
| Post-discharge outcomes | All patients (N = 153,696) |
By ADRD status | |
|---|---|---|---|
| Non-ADRD (N = 53,410) |
ADRD (N = 100,286) |
||
| Burdensome transitions | |||
| Transition type 1 | 9.1 | 10.3 | 8.5 |
| Transition type 2 | 2.8 | 4.0 | 2.2 |
| 30-day post-discharge outcomes, % | |||
| Any ED visits | 10.6 | 11.5 | 10.1 |
| Any hospitalizations | 30.8 | 32.7 | 29.8 |
| Hospice readmission | 27.7 | 33.3 | 24.7 |
| 30-day mortality | 18.5 | 24.7 | 15.2 |
| 180-day post-discharge outcome, % | |||
| Any ED visits | 23.9 | 24.0 | 23.8 |
| Any hospitalizations | 41.5 | 43.5 | 40.5 |
| Hospice readmission | 41.7 | 45.2 | 39.8 |
| 180-day mortality | 42.1 | 50.3 | 37.8 |
| EoL outcomes, % | |||
| Any ED visits | 32.1 | 30.9 | 32.8 |
| Any hospitalizations | 56.1 | 56.9 | 55.7 |
| Hospice readmission | 72.5 | 70.3 | 73.8 |
ADRD Alzheimer’s disease and related dementias, ED emergency department, EoL end of life. Burdensome transition type 1 refers to live discharges from hospice followed by a hospitalization within 2 days and followed by a hospice readmission within 2 days of hospital discharge. Burdensome transition type 2 refers to live discharges from hospice followed by a hospitalization within 2 days, and where the patient also died during the inpatient hospitalization stay.